Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Corrigendum to: Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association with Tumor Mutation Burden, Prognosis, and Immune Regulation.

Combinatorial chemistry & high throughput screening - 1 Jan 2026

Luo Yu, Zhang Min, Wang Zhibo, Li Zhihua, Chen Xiru, Cao Juan, Que Jun, Chen Liang, Deng Xiaheng

Abstract excerpt

It has come to our notice that in the published version of this article [1], the asterisk denoting the corresponding author was inadvertently omitted. The corrected author list is provided below. The original article can be found online at https://benthamscience.com/public/article/144076 Details of the correction: • Original: Yu Luo1,*, Min Zhang2,*, Zhibo Wang1,*, Zhihua Li1, Xiru Chen1, Juan Cao1, Jun Que1,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 42003235
DOI: 10.2174/138620732902251118163210

Genes

SVEP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Corrigendum to: Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association with Tumor Mutation Burden, Prognosis, and Immune Regulation.PMID 42003235Read ↗

Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association with Tumor Mutation Burden, Prognosis, and Immune Regulation.Semantic proximity Read ↗

Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacySemantic proximity Read ↗

Genetic Alterations in NSCLC: Prognostic Implications and Impact on Therapeutic Resistance.Semantic proximity Read ↗

Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung CancerSemantic proximity Read ↗

The Current Roadmap of Lung Cancer Biology, Genomics and Racial DisparitySemantic proximity Read ↗

Molecular Targets Beyond the Big 3.Semantic proximity Read ↗

Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.Semantic proximity Read ↗

Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population.Semantic proximity Read ↗

Prognostic Values, ceRNA Network, and Immune Regulation Function of SDPR in KRAS-mutant Lung CancerSemantic proximity Read ↗

Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trialsSemantic proximity Read ↗

The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival ratesSemantic proximity Read ↗

[Advances on driver oncogenes of non-small cell lung cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.